Calibre Scientific has acquired DCS Innovative Diagnostik-Systeme GmbH & Co. KG, enhancing its diagnostic product offerings and footprint in the DACH region.

Information on the Target

Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG ("DCS"), a prominent German supplier specializing in reagents and equipment for immunohistochemistry. DCS primarily serves diagnostic, research, industrial, university, and hospital sectors, focusing particularly on clinical pathology and oncology markets. With this strategic acquisition, Calibre Scientific enhances its product and service offerings throughout the DACH region.

Founded in 1992 and headquartered in Hamburg, DCS has established itself as a leading entity in immunohistochemistry, providing a comprehensive range of primary antibodies, secondary reagents, detection systems, and automation solutions. The company's longstanding presence in the market allows it to effectively cater to laboratories, hospitals, and educational institutions throughout the DACH region.

Industry Overview in the Target's Specific Country

The life sciences industry in Germany demonstrates robust growth and innovation, driven by advances in healthcare and biotechnology. With one of the largest markets in Europe, Ge